Conroy Kevin T
SEC-identified person · CIK 1306119 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Align Technology INC ALGn | Director | filed 2023 - 2026 |
| Abbott Laboratories ABT | Director | filed 2026 - 2026 |
| Exact Sciences Corp EXAS | Director · Vice President | filed 2009 - 2026 |
| American Exceptionalism Acquisition Corp. A AEXA | Director | filed 2025 - 2025 |
| Adaptive Biotechnologies Corp ADPT | Director | filed 2019 - 2023 |
| Epizyme, Inc. EPZM | Director | filed 2017 - 2022 |
| Somalogic, Inc. slgc | Director | filed 2021 - 2021 |
| Arya Sciences Acquisition Corp. ARYA | Director | filed 2018 - 2020 |
| Third Wave Technologies INC /WI twti | Director · President and CEO | filed 2006 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.